Current Ratio of Calidi Biotherapeutics, Inc. from 30 Jun 2022 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
Calidi Biotherapeutics, Inc. quarterly Current Ratio in x history and change rate from 30 Jun 2022 to 31 Dec 2025.
- Calidi Biotherapeutics, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 1.75x, a 436% increase year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
Calidi Biotherapeutics, Inc. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 1.75x | +1.42x | +436% | 31 Dec 2025 |
| Q3 2025 | 1.52x | +1.32x | +652% | 30 Sep 2025 |
| Q2 2025 | 0.94x | +0.54x | +136% | 30 Jun 2025 |
| Q1 2025 | 0.65x | +0.22x | +53% | 31 Mar 2025 |
| Q4 2024 | 0.33x | -0.15x | -31% | 31 Dec 2024 |
| Q3 2024 | 0.2x | +0.01x | +2.7% | 30 Sep 2024 |
| Q2 2024 | 0.4x | +0.36x | +910% | 30 Jun 2024 |
| Q1 2024 | 0.42x | +0.38x | +847% | 31 Mar 2024 |
| Q4 2023 | 0.48x | +0.41x | +601% | 31 Dec 2023 |
| Q3 2023 | 0.2x | -1.3x | -87% | 30 Sep 2023 |
| Q2 2023 | 0.04x | -4.29x | -99% | 30 Jun 2023 |
| Q1 2023 | 0.04x | 31 Mar 2023 | ||
| Q4 2022 | 0.07x | 31 Dec 2022 | ||
| Q3 2022 | 1.5x | 30 Sep 2022 | ||
| Q2 2022 | 4.33x | 30 Jun 2022 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.